טוען...
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2
The novel coronavirus (SARS-CoV-2) outbreak has started taking away the millions of lives worldwide. Identification of known and approved drugs against novel coronavirus disease (COVID-19) seems to be an urgent need for the repurposing of the existing drugs. So, here we examined a safe strategy of u...
שמור ב:
| הוצא לאור ב: | J Pharm Sci |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Pharmacists Association®. Published by Elsevier Inc.
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7934671/ https://ncbi.nlm.nih.gov/pubmed/33684397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xphs.2021.03.004 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|